Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2005
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005US20050065201 Fungicides in human, animals; controlling plant diseases; reacting 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethanol with halogen substituted benzthiophene compoundu
03/24/2005US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis
03/24/2005US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065099 Treatment of mitochondrial diseases
03/24/2005US20050064415 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/24/2005US20050064333 polymerization catalysts such as 5-(2,4-dimethylphenyl) thianthrenium hexafluoroantimonate, used for polymerization of epoxy and vinyl ether monomers
03/24/2005CA2538552A1 Pyrrol derivatives with antibacterial activity
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1515964A1 Substituted diaminopyrimidines
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1427725B1 Pyrazolyl-substituted thienyloxypyridines
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1597680A New method of synthesizing thalidomide and its derivative
03/23/2005CN1597677A Compounds and methods for modulation of estrogen receptors
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/22/2005US6870052 Preparation of thioarabinofuranosyl compounds and use thereof
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869969 Isoxazole estrogen receptor agonist and antagonist
03/22/2005US6869957 Non-peptide tachykinin receptor antagonists
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869696 Organic red electro-luminescent device including a heterocyclic emitter
03/17/2005WO2005024440A2 Polarizing agents for dynamic nuclear polarization
03/17/2005WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents
03/17/2005WO2005023800A1 Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
03/17/2005WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use
03/17/2005WO2005023794A2 Compound libraries of 4-carboxamidopiperidine derivatives
03/17/2005WO2005023773A1 Process for the preparation of substituted aryl pyrazoles
03/17/2005WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005005415A8 Indoles useful in the treatment of inflammation
03/17/2005WO2004092196A3 Tie-2 modulators and methods of use
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005WO2003053959A8 Heterocyclylamino carbonyluracils
03/17/2005WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders
03/17/2005WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd
03/17/2005US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
03/17/2005US20050059673 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
03/17/2005US20050059668 Substituted acylpiperazine derivatives
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050058917 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups
03/17/2005US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders
03/17/2005US20050056293 Reduced ignition propensity smoking article
03/17/2005DE10306502B4 Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel Substituted 3- (Benzoylureido) -thiophenderivate and medicaments containing them
03/17/2005CA2577909A1 Polarizing agents for dynamic nuclear polarization
03/17/2005CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents
03/17/2005CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005CA2536930A1 Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
03/16/2005EP1513911A1 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
03/16/2005EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1250047B1 Herbicidal composition
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596250A Paclitaxel solvates
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1193027C Substituted pyrroles